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Abstract
Background
Inflammation contributes to breast cancer development through its effects on cell damage.
This damage is usually dealt with by key genes involved in apoptosis and autophagy
pathways.
Methods
We tested 206 single nucleotide polymorphisms (SNPs) in 54 genes related to inflammation,
apoptosis and autophagy in a population-based breast cancer study of women of European
(658 cases and 795 controls) and East Asian (262 cases and 127 controls) descent. Logistic
regression was used to estimate odds ratios for breast cancer risk, and case-only analysis
to compare breast cancer subtypes (defined by ER/PR/HER2 status), with adjustment for
confounders. We assessed statistical interactions between the SNPs and lifestyle factors
(smoking status, physical activity and body mass index).
Results and conclusion
Although no SNP was associated with breast cancer risk among women of European
descent, we found evidence for an association among East Asians for rs1800925 (IL-13) and
breast cancer risk (OR = 2.08; 95% CI: 1.32–3.28; p = 0.000779), which remained statistically
significant after multiple testing correction (padj = 0.0350). This association was replicated in
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a meta-analysis of 4305 cases and 4194 controls in the Shanghai Breast Cancer Genetics
Study (OR 1.12, 95% CI: 1.03–1.21, p = 0.011). Further, we found evidence of an interaction
between rs7874234 (TSC1) and physical activity among women of East Asian descent.
Introduction
Chronic inflammation has been linked to cancer development [1], and can influence breast
cancer through many mechanisms [2]. One way that chronic inflammation can contribute to
cancer is through persistent damage to cells and their components such as DNA. Apoptosis
and autophagy are two of the main processes that respond to the consequences of damage
caused by inflammation. Proteins involved in inflammation and apoptosis are associated with
the invasiveness of breast cancer lines [3] and the maintenance of stem cell properties [4].
Lifestyle factors such as smoking introduce sources of inflammation to breast tissue. Several
studies suggest a causal association between lifestyle factors and breast cancer susceptibility or
progression. For example, in premenopausal women, obesity can affect hormone-independent
breast cancer through chronic inflammation of the breast adipose tissue [5]. In addition, inher-
ited factors could aggravate chronic damage from inflammation, or alternately offset damage
and thus protect tissues from inflammation. Genes involved in inflammation and apoptosis
have previously been associated with cancer prognosis, [6,7] as well as susceptibility [8–10].
Breast cancers may be classified by pathologists using hormone receptor status (the estro-
gen receptor [ER] and progesterone receptor [PR]), or HER2 growth receptor status. Some
associations of different genes to risk are limited to only certain tumour subtypes [7,11], which
hint at etiological and biological differences between subtypes and suggest a benefit in examin-
ing the subtypes separately when enough samples and information are available.
The objective of this study was to replicate previously reported associations of polymor-
phisms in genes related to inflammation, apoptosis and autophagy with risk of breast cancer in
women of European and East Asian descent. Within these three gene categories, we included
additional genes previously shown to have an effect on cancer. We also tested for statistical
interactions of these genes with lifestyle factors that could affect inflammation, including body
mass index (BMI), physical activity and smoking status. Finally, we carried out case-only anal-
yses to examine whether these SNPs may have breast tumour subtype specific effects.
Materials and methods
Samples and SNPs
This study was approved by the joint Clinical Research Ethics Board of the University of Brit-
ish Columbia and BC Cancer. All participants gave written informed consent.
In brief, the Canadian Breast Cancer Study, a population-based case-control study, invited
women with in situ or invasive breast cancer, diagnosed from April 2005 to May 2009 [12].
Women were aged 20 to 80 and lived in Metro Vancouver, British Columbia (BC) or Kingston,
Ontario regions of Canada. In Vancouver, women were recruited through the BC Cancer Reg-
istry, and age-frequency matched controls were recruited through the Screening Mammogra-
phy Program of BC. In Kingston, cases and controls were recruited from the Hotel Dieu Breast
Assessment Program. DNA was obtained through a blood (91%) or saliva sample (9%). Addi-
tional information (including menopausal status, ethnicity, and lifestyle characteristics) was
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obtained through a questionnaire, either by computer assisted telephone interview (22.2%) or
self-administered (77.8%).
Fifty-two genes related to apoptosis, autophagy and inflammation were studied (Table 1),
eight of which had previously identified tagSNPs [13]. Thirty-eight genes were tagged using
Tagger [14] in Haploview [15] with HapMap CEU population data (Table 1). Additional SNPs
were selected for replication of findings from other studies; this resulted in addition of SNPs
for 10 candidate genes, and 7 genes with only replication SNPs (Table 1). Genotyping was
done as part of an Illumina Golden Gate Assay (San Diego, CA, USA) at the Genome Quebec /
McGill University Innovation Centre.
Quality control was performed by the authors as described in [12], using Illumina Genome
Studio v2011.1 (San Diego, CA, USA), PLINK v1.07 [16], GRR [17] and Microsoft Excel 2007
(Redmond, WA, USA). Of the 221 SNPs selected, 15 (7%) failed quality control for the follow-
ing reasons: failure in Illumina’s built-in controls (n = 6), GenTrain Score<0.4 (n = 2), poor
clusters (n = 4), monoallelic (n = 2), and call rate<0.95 (n = 1) (S1 Table).
For this analysis, only individuals of European and East Asian descent were included
(Table 2). Hormone receptor status (ER, PR and HER2 status) was determined using immu-
nohistochemistry and fluorescence in situ hybridization, as previously described [18], and
tumour marker status was dichotomized as “present” or “absent”, as opposed to the cut-off lev-
els of staining used for clinical purposes.
Statistical analysis
Statistical analyses were carried out in SVS (Golden Helix, Inc., Bozeman, MT, USA) and R
(version 3, R Foundation for Statistical Computing, Vienna, Austria) [19]. Logistic regression
was carried out in European and East Asian women separately, with the inclusion of terms for
age group, region of collection, menopausal status, and two interaction terms: menopausal sta-
tus—age group, and menopausal status–region of collection. Multiple testing correction was
applied using the false discovery rate method (FDR) [20] in two stages, as described previously
[21]. Briefly, FDR was applied within each gene first, to give a corrected p-value for each test.
The lowest p-value was taken to represent each gene, and finally another round of FDR was
applied to yield corrected p-values across all the genes tested. This allows correction for the dif-
ferent number of SNPs in each gene, as well as the number of genes tested. FDR-corrected p-
values of less than 0.05 were taken to indicate an association of the SNP with breast cancer.
SNPs that had p<0.05 before multiple testing correction were tested for interaction with
being overweight/obese at the time of diagnosis (defined as BMI�25), smoking status (non-
smokers vs. pack-years>0) and total lifetime physical activity. Total lifetime physical activity
measurements were measured as previously described [22,23] and included leisure-time,
household, and occupational activities of moderate-to-vigorous intensity, summarized using
metabolic equivalent (MET) scores (which are the ratio of the calculated metabolic rate for a
specific activity compared to resting metabolic rate). In interaction analyses described here
and previous work [24], active women were those>89.6 MET hrs/wk (the mean value among
controls, which can be approximated by running at a fast pace for a bit under an hour per
day). If there was a significant interaction, odds ratios for that SNP were computed within
each stratum. Interaction analyses were done separately for Europeans and East Asians. Addi-
tional analysis to compare the effect of rs7874234 with regards to lifetime physical activity (in
East Asian women) was conducted using StatPlus:mac (AnalystSoft Inc., Walnut, CA, USA).
Finally, logistic regression using only the cases was utilized to examine heterogeneity by hor-
mone (ER/PR) receptor status and HER2 status using the categories indicated in Table 2. Anal-
ysis was only done for SNPs with p<0.05 before multiple testing correction. We did not have
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Table 1. Genes studied.
Category Gene Tagged Replication SNPs Reference
Apoptosis BAX X
BBC3/PUMA X
BMI1 X
FAS X
MDM2 X
MIR125A X
MIR145 X
miR15a X
MIR206 X
MIR26A1 X
MIR30A X
MIRN155 X
MIRN155 X
PMAIP1/NOXA X
RFWD2 X
SKP2 X
Apoptosis & Autophagy BCL2 X
BECN1 X
MDM2 rs2279744 & rs937282 Gansmo et al. 2015, PubMed ID 26471763
pre-miRNA-27a rs895819 Yang et al. 2010, PubMed ID 19921425
TP53 X
Autophagy AKT1 X
ATG16L1 rs2241880 In Crohn’s disease: Grant et al. 2008, PubMed ID 18366306
DRAM X
FKBP1A X
FLJ20294 X
FRAP1 X
KIAA0226 X
KIAA0831 X
LKB1/STK11 X
PARK2 X
PTEN X
TSC1 X rs7874234 Mehta et al. 2011, PubMed ID 20658316
TSC2 X
H2AFX-related H2AFX X
YY1 X
Inflammation CASP8 Caspase-8 � rs1045485 Reviewed role in inflammation: Loza et al. 2007, PubMed ID 17940599
CFH Complement factor H � rs1061170 Reviewed role in inflammation: Loza et al. 2007, PubMed ID 17940599
CTLA4 � rs3087243 Reviewed role in inflammation: Loza et al. 2007, PubMed ID 17940599
IFIH1 Mda-5, Helicard � rs1990760 Reviewed role in inflammation: Loza et al. 2007, PubMed ID 17940599
IL-13 rs1800925 Erdei et al. 2010, PubMed ID 20418110
IL-4 rs2243248 Erdei et al. 2010, PubMed ID 20418110
IL-10 X
IL-6 X
IL1B X
IL23R X
IL4R � rs1801275 Reviewed role in inflammation: Loza et al. 2007, PubMed ID 17940599
(Continued)
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samples in each genotype category for the HER2 status case-only analysis in East Asian samples,
as the minor allele frequencies were too low. Multiple-testing correction was applied to all SNPs
Table 1. (Continued)
Category Gene Tagged Replication SNPs Reference
INF gamma rs2069705 Erdei et al. 2010, PubMed ID 20418110
IRF5 � rs2004640 Reviewed role in inflammation: Loza et al. 2007, PubMed ID 17940599
MAPK14 X
PTPN22 � rs2476601 Reviewed role in inflammation: Loza et al. 2007, PubMed ID 17940599
SEPS1 rs28665122 Role in inflammation: Curran et al. 2005, PubMed ID 16227999
TGFB1 � rs1982073 Reviewed role in inflammation: Loza et al. 2007, PubMed ID 17940599
TNF-alpha � rs1800629 & rs361525 Reviewed role in inflammation: Loza et al. 2007, PubMed ID 17940599
� Tag from Loza et al 2007
https://doi.org/10.1371/journal.pone.0209010.t001
Table 2. Characteristics of participants whose samples passed quality control.
European East Asian
Controls Cases Controls Cases
Region
Vancouver, Canada 721 573 127 262
Kingston, Canada 74 85 0 0
Age group (years)
20–29 0 2 0 1
30–39 5 20 0 17
40–49 202 148 53 97
50–59 271 212 34 68
60–69 201 169 30 46
70+ 116 107 10 33
Menopausal Status
Premenopausal 268 189 66 107
Postmenopausal 525 446 61 137
Hormone Receptor Status
ER and/or PR positive 0 477 0 174
ER/PR negative 0 100 0 29
HER2 Status
Negative 0 532 0 206
Positive 0 105 0 38
BMI
<25 458 308 103 200
25+ 336 329 24 44
Smoking Status
Non-smoker 406 295 111 220
Smoker 388 342 16 24
Physical Activity
<89.6 MET hrs/wk 383 329 77 137
>89.6 MET hrs/wk 401 293 49 101
Total 795 658 127 262
https://doi.org/10.1371/journal.pone.0209010.t002
Genetic risk in inflammation, apoptosis & autophagy
PLOS ONE | https://doi.org/10.1371/journal.pone.0209010 January 2, 2019 5 / 12
that underwent case-only analysis. Additional analysis to compare the effect of rs7236090 in dif-
ferent hormone receptor status groups in East Asian women was also done using StatPlus:mac.
Replication analysis
Participants in the Shanghai Breast Cancer Genetics Study (SBCGS) are from four population-
based studies: the Shanghai Breast Cancer Study (SBCS), the Shanghai Women’s Health Study
(SWHS), the Shanghai Breast Cancer Survival Study (SBCSS) and the Shanghai Endometrial
Cancer Study (SECS, controls only). Detailed descriptions of these studies have been published
elsewhere [25]. Briefly, the SBCS included two recruitment phases, SBCS-I (1996–1998) and
SBCS-II (2002–2005). Breast cancer cases were identified through a rapid case ascertainment
system and the Shanghai Cancer Registry. Controls were randomly selected from the general
female population using the Shanghai Resident Registry and were frequency matched to cases
by age. The SBCSS included newly diagnosed breast cancer cases ascertained via the Shanghai
Cancer Registry between 2002–2006. The SECS was conducted from 1997–2003; only commu-
nity controls from the SECS were included in the SBCGS. The SWHS is a prospective cohort
study recruited from 1996–2000. The cohort has been followed by a combination of record link-
age and active follow-ups to identify cause-specific mortality and cancer incidence by site.
These studies are conducted among Chinese women in Shanghai using very similar protocols
for data and sample collection: 2,511 breast cancer cases and 2,135 controls were genotyped
using an Affymetrix 6.0 array; another 1,794 cases and 2,059 controls were genotyped using the
Illumina Multi-Ethnic Genotyping Array. Data quality control procedures were carried out as
previously described [25], followed by imputation with 1000 Genomes Project Phase 3 as refer-
ence. Logistic regression was performed under an additive model, with adjustment for age and
the top five principal components. Data for SNPs rs1800925 and rs7874234 were extracted.
Results
Characteristics of the cases and controls are summarized in Table 2. Briefly, quality control
measures resulted in data for 922 controls and 920 cases for 206 SNPs (S1 Table). Following
logistic regression analysis in Europeans (658 cases and 795 controls), 3 SNPs had p<0.05
before FDR correction and none had p<0.05 after multiple testing correction (S2 Table): (i)
rs6676805 (RFWD2) (OR = 0.730 (95% CI: 0.600–0.889) p = 0.00158 and after correction padj
= 0.213), (ii) rs617078 (RFWD2) (OR = 0.799 (95% CI: 0.681–0.938) p = 0.00585) and (iii)
rs8063461 (TSC2) (OR = 0.823 (95% CI 0.711–0.963) p = 0.00139 and after correction padj =
0.960). There was no evidence for an interaction of any of the three SNPs with excess weight,
smoking status, or exercise (S2 Table). There was also no evidence for differential effects
depending on the tumour subtype as determined by hormone receptor status (S2 Table).
Among East Asian women (262 cases and 127 controls), 7 SNPs had p<0.05 before multiple
testing correction (Table 3). Following FDR correction, the SNP rs1800925 (IL-13) was associated
with breast cancer risk (OR = 2.08 (95% CI: 1.32–3.28) p = 0.000779; after correction padj = 0.0350).
Among East Asian women, SNP rs7874234 (TSC1) (OR = 1.81 (95% CI: 1.00–3.28) p = 0.0418;
after correction padj = 1.00) interacted with physical activity (p = 0.0281). When separating cases
by physical activity totals, the association between rs7874234 and breast cancer risk was only seen
in women with an average lifetime weekly exercise of<89.6 MET hrs (OR = 1.24 (95% CI: 1.05–
1.46) p = 0.00909), with no association for women with>89.6 MET hrs.
Finally, rs7236090 (BCL2) (OR = 0.713 (95% CI:0.515–0.986) p = 0.0396) was differentially
associated in the hormone receptor (ER/PR) classified tumour subtypes in East Asian women
(p = 0.00612; after correction padj = 0.0429), with the strongest association seen for hormone
receptor positive tumours.
Genetic risk in inflammation, apoptosis & autophagy
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We tested the IL-13 and TSC1 SNPs for replication of main effects by conducting lookups in
genome-wide association study (GWAS) data from the Shanghai Breast Cancer Genetics Study
(SBCGS) [25]. Rs1800925 in IL-13 was significantly associated with breast cancer in one of two
data sets tested, as well as in an overall meta-analysis of the SBCGS data (4305 cases and 4194
controls; OR 1.12, (95% CI: 1.03–1.21) p = 0.011) (Table 4), with the same direction of associa-
tion as in the Canadian data. Because exercise data was not available for the SBCGS, we were not
able to test rs7874234 in TSC1 for interaction with exercise in the replication study. No main
effect for association with breast cancer risk was observed for this SNP in the SBCGS (Table 4).
Discussion
We report an association between rs1800925 (IL-13) and breast cancer risk among East Asian
women, which was not heterogeneous across breast cancer subtypes. IL-13 was associated with
breast cancer risk in New Mexico [26]. A previous GWAS in the SBCGS did not report this
SNP as associated with breast cancer at a genome-wide significance level [25,27], nor was it
associated with breast cancer survival in Chinese women [28]. In a replication by data lookup
in the SBCGS GWAS data, we found that the p-value and direction of association were consis-
tent with association of this SNP with breast cancer in East Asian women. The odds ratio for
association in the larger study was smaller, 1.12 rather than 2.08, which likely means that the
true effect size is quite small. Alternatively, it is possible that the effect size is larger among East
Table 3. Logistic regression and interaction analysis results for East Asian samples for SNPs with p<0.05 before FDR.
Interaction p-value
SNP Gene Alleles (Major/
Minor)
Minor Allele
Frequ.
OR 95% CI p-value FDR-corrected p-
value
obesity smoking
status
exercise ER/PR status
corrected p-value
rs1800925 IL-13 G/A 0.167 2.08 1.32–3.28 0.000779 0.0350 0.486 0.805 0.746 0.720
rs353291 MIR145 A/G 0.489 0.657 0.483–
0.895
0.00704 0.158 0.396 0.782 0.933 0.526
rs2032809 BBC3/
PUMA
G/A 0.438 1.47 1.07–2.03 0.0163 0.488 0.496 0.767 0.845 0.721
rs6676805 RFWD2 C/G 0.310 1.48 1.06–2.08 0.0203 0.686 0.717 0.542 0.157 0.973
rs7731023 SKP2 A/G 0.089 0.58 0.351–
0.959
0.0343 1.00 0.986 0.910 0.143 0.767
rs7236090 BCL2 A/G 0.457 0.713 0.515–
0.986
0.0396 1.00 0.984 0.967 0.551 0.0429
rs7874234 TSC1 G/A 0.101 1.81 1.00–3.28 0.0418 1.00 0.982 0.930 0.0281 0.607
https://doi.org/10.1371/journal.pone.0209010.t003
Table 4. Replication results in the Shanghai breast cancer genetics study.
SNP Gene Alleles (Major/Minor)� Data set Minor Allele Frequ. OR 95% CI P-value
rs1800925 IL-13 C/T Data1 0.162 1.09 0.97–1.24 0.164
Data2 0.175 1.14 1.01–1.28 0.03
Meta 0.169 1.12 1.03–1.21 0.011
rs7874234 TSC1 C/T Data1 0.103 1.03 0.89–1.19 0.725
Data2 0.097 0.91 0.79–1.05 0.181
Meta 0.1 0.96 0.87–1.07 0.46
�Replication assays genotyped the opposite strand of those used in the discovery analysis; for both SNPs the minor allele is referred to as A in the discovery data and as T
in the replication data.
https://doi.org/10.1371/journal.pone.0209010.t004
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Asian women in Canada, potentially because they are not identical in ethnicity to women in
Shanghai, or because of different environmental contexts. Observation of this association in
two studies of East Asian women may mean that the association may be real (i.e., not a false
positive), although it did not reach genome-wide significance in the original GWAS in the
SBCGS. This SNP has also been associated with a shorter time to recurrence among those with
early stage breast cancer [29].
In the literature, the evidence for associations with the other genes we tested was inconclu-
sive. We were unable to replicate associations with (i) IL-6, as previously found in 6292 cases
and 8135 controls from Germany [30], 2325 cases and 2525 controls from North America [31],
and 305 cases and 200 controls from Tunisia [32]; or (ii) FAS, as previously found in a meta-
analysis of Asian populations [33] and in a study of 1053 cases and 1102 controls from New
York, USA [34]. This may be due to insufficient power in our study because of smaller numbers
(922 controls and 920 cases compared to other studies [30,31,34]), or because the tagSNP
approach did not examine the SNP for which the association was reported [30,31]. Alterna-
tively, for SNPs such as rs1800795 [32], which was tested with sufficient power in women of
European ancestry, the difference could be attributed to population-specific genetic differences,
or to a true failure to replicate a previous false positive. Consistent with our findings, other stud-
ies also found no role for the same genes we tested in studies where populations enrolled were
not enriched for positive cancer family history (for example, TNF-a [35] or MDM2 [36]).
The association of CASP8 with breast cancer depended on BRCA1/BRCA2 mutation carrier
status in some studies [37], but not others [38,39]. TP53 variants are associated with breast
cancer only in BRCA2 carriers [40], not in the general population [41]. Pre-miR-27a polymor-
phisms were associated with familial, but not sporadic, breast cancer [42]. As we do not have
information for the BRCA1 and BRCA2 mutation status of the women in our study, and such
women would likely be a minority of those in our study, we are unlikely to detect associations
that only apply to mutation carriers.
We found evidence that, in East Asian women, breast cancer risk conferred by rs7874234
(TSC1) could be attenuated by physical activity, as women with high total physical activity
scores (>89.6 MET hrs/wk) no longer had significant association for breast cancer risk.
Although obesity and smoking are known to contribute to inflammation, we did not find evi-
dence for an interaction between these factors and genetic influencers of inflammation.
Finally, we observed heterogeneity by tumour subtype for the BCL2 SNP rs7236090, for
which the minor allele was protective of breast cancer. BCL2 has been described as a favour-
able prognostic marker for all types of early-stage breast cancer [43]. In our dataset among
East Asian women, the protective effect was strongest in women with ER/PR positive tumours,
a lower risk subgroup of breast cancer.
Overall, we found evidence for associations with breast cancer risk with single SNPs in 2
genes (RFWD2 and TSC2) among women of European descent, but neither remained statisti-
cally significant after correction for multiple testing. We found one SNP in IL-13 associated
with breast cancer among women of East Asian descent that remained statistically significant
after multiple testing correction, and this was replicated in the SBCGS. Six other SNPs had evi-
dence for an association in East Asian women before multiple testing correction; of these, one
in TSC1 appears to interact with physical activity.
It is important not to over-interpret the apparent negative results for many genes. We did
not fully tag these genes, on average using 5 SNPs per gene and an r2 cutoff of 0.8, so there may
be some unrepresented genetic variation. Even if many genes have an apparent null association
with breast cancer risk, these pathways could still be important. For example, polymorphisms
in microRNA binding sites, but not in the microRNAs themselves, have been associated with
breast cancer [44]. Recent genome-wide association studies of breast cancer have revealed a
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strong enrichment for SNPs in distal transcription factor binding sites [45], which our study
did not capture. Further, our relatively small sample size limited our power to detect individual
SNPs with very small effects.
In conclusion, we replicated an association of SNP rs1800925 in IL-13 with breast cancer
risk among women of East Asian descent, and not among women of European descent. We
also provide evidence that the TSC1 SNP rs7874234 may interact with physical activity to influ-
ence breast cancer risk. Finally, we find that rs7236090 in BCL2 has the strongest protective
effect associated with hormone receptor positive breast cancer subtype among women of East
Asian descent. These findings support the importance of considering potential environmental
interactions in genetic susceptibility models, while finding an approach that balances the
increased number of statistical tests conducted.
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